Cargando…

Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study

BACKGROUND: Generalised anxiety disorder (GAD) is the most common anxiety disorder in older people. First-line management includes pharmacological and psychological therapies, but many do not find these effective or acceptable. Little is known about how to manage treatment-resistant generalised anxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gould, Rebecca L, Wetherell, Julie Loebach, Kimona, Kate, Serfaty, Marc A, Jones, Rebecca, Graham, Christopher D, Lawrence, Vanessa, Livingston, Gill, Wilkinson, Philip, Walters, Kate, Le Novere, Marie, Leroi, Iracema, Barber, Robert, Lee, Ellen, Cook, Jo, Wuthrich, Viviana M, Howard, Robert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437065/
https://www.ncbi.nlm.nih.gov/pubmed/33852722
http://dx.doi.org/10.1093/ageing/afab059
_version_ 1783752100963942400
author Gould, Rebecca L
Wetherell, Julie Loebach
Kimona, Kate
Serfaty, Marc A
Jones, Rebecca
Graham, Christopher D
Lawrence, Vanessa
Livingston, Gill
Wilkinson, Philip
Walters, Kate
Le Novere, Marie
Leroi, Iracema
Barber, Robert
Lee, Ellen
Cook, Jo
Wuthrich, Viviana M
Howard, Robert J
author_facet Gould, Rebecca L
Wetherell, Julie Loebach
Kimona, Kate
Serfaty, Marc A
Jones, Rebecca
Graham, Christopher D
Lawrence, Vanessa
Livingston, Gill
Wilkinson, Philip
Walters, Kate
Le Novere, Marie
Leroi, Iracema
Barber, Robert
Lee, Ellen
Cook, Jo
Wuthrich, Viviana M
Howard, Robert J
author_sort Gould, Rebecca L
collection PubMed
description BACKGROUND: Generalised anxiety disorder (GAD) is the most common anxiety disorder in older people. First-line management includes pharmacological and psychological therapies, but many do not find these effective or acceptable. Little is known about how to manage treatment-resistant generalised anxiety disorder (TR-GAD) in older people. OBJECTIVES: To examine the acceptability, feasibility and preliminary estimates of the effectiveness of acceptance and commitment therapy (ACT) for older people with TR-GAD. PARTICIPANTS: People aged ≥65 years with TR-GAD (defined as not responding to GAD treatment, tolerate it or refused treatment) recruited from primary and secondary care services and the community. INTERVENTION: Participants received up to 16 one-to-one sessions of ACT, developed specifically for older people with TR-GAD, in addition to usual care. MEASUREMENTS: Co-primary outcomes were feasibility (defined as recruitment of ≥32 participants and retention of ≥60% at follow-up) and acceptability (defined as participants attending ≥10 sessions and scoring ≥21/30 on the satisfaction with therapy subscale). Secondary outcomes included measures of anxiety, worry, depression and psychological flexibility (assessed at 0 and 20 weeks). RESULTS: Thirty-seven participants were recruited, 30 (81%) were retained and 26 (70%) attended ≥10 sessions. A total of 18/30 (60%) participants scored ≥21/30 on the satisfaction with therapy subscale. There was preliminary evidence suggesting that ACT may improve anxiety, depression and psychological flexibility. CONCLUSIONS: There was evidence of good feasibility and acceptability, although satisfaction with therapy scores suggested that further refinement of the intervention may be necessary. Results indicate that a larger-scale randomised controlled trial of ACT for TR-GAD is feasible and warranted.
format Online
Article
Text
id pubmed-8437065
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84370652021-09-14 Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study Gould, Rebecca L Wetherell, Julie Loebach Kimona, Kate Serfaty, Marc A Jones, Rebecca Graham, Christopher D Lawrence, Vanessa Livingston, Gill Wilkinson, Philip Walters, Kate Le Novere, Marie Leroi, Iracema Barber, Robert Lee, Ellen Cook, Jo Wuthrich, Viviana M Howard, Robert J Age Ageing Research Paper BACKGROUND: Generalised anxiety disorder (GAD) is the most common anxiety disorder in older people. First-line management includes pharmacological and psychological therapies, but many do not find these effective or acceptable. Little is known about how to manage treatment-resistant generalised anxiety disorder (TR-GAD) in older people. OBJECTIVES: To examine the acceptability, feasibility and preliminary estimates of the effectiveness of acceptance and commitment therapy (ACT) for older people with TR-GAD. PARTICIPANTS: People aged ≥65 years with TR-GAD (defined as not responding to GAD treatment, tolerate it or refused treatment) recruited from primary and secondary care services and the community. INTERVENTION: Participants received up to 16 one-to-one sessions of ACT, developed specifically for older people with TR-GAD, in addition to usual care. MEASUREMENTS: Co-primary outcomes were feasibility (defined as recruitment of ≥32 participants and retention of ≥60% at follow-up) and acceptability (defined as participants attending ≥10 sessions and scoring ≥21/30 on the satisfaction with therapy subscale). Secondary outcomes included measures of anxiety, worry, depression and psychological flexibility (assessed at 0 and 20 weeks). RESULTS: Thirty-seven participants were recruited, 30 (81%) were retained and 26 (70%) attended ≥10 sessions. A total of 18/30 (60%) participants scored ≥21/30 on the satisfaction with therapy subscale. There was preliminary evidence suggesting that ACT may improve anxiety, depression and psychological flexibility. CONCLUSIONS: There was evidence of good feasibility and acceptability, although satisfaction with therapy scores suggested that further refinement of the intervention may be necessary. Results indicate that a larger-scale randomised controlled trial of ACT for TR-GAD is feasible and warranted. Oxford University Press 2021-04-13 /pmc/articles/PMC8437065/ /pubmed/33852722 http://dx.doi.org/10.1093/ageing/afab059 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Paper
Gould, Rebecca L
Wetherell, Julie Loebach
Kimona, Kate
Serfaty, Marc A
Jones, Rebecca
Graham, Christopher D
Lawrence, Vanessa
Livingston, Gill
Wilkinson, Philip
Walters, Kate
Le Novere, Marie
Leroi, Iracema
Barber, Robert
Lee, Ellen
Cook, Jo
Wuthrich, Viviana M
Howard, Robert J
Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study
title Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study
title_full Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study
title_fullStr Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study
title_full_unstemmed Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study
title_short Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study
title_sort acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437065/
https://www.ncbi.nlm.nih.gov/pubmed/33852722
http://dx.doi.org/10.1093/ageing/afab059
work_keys_str_mv AT gouldrebeccal acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT wetherelljulieloebach acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT kimonakate acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT serfatymarca acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT jonesrebecca acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT grahamchristopherd acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT lawrencevanessa acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT livingstongill acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT wilkinsonphilip acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT walterskate acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT lenoveremarie acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT leroiiracema acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT barberrobert acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT leeellen acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT cookjo acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT wuthrichvivianam acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy
AT howardrobertj acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy